Biomarin Pharmaceutical Inc
XBER:BM8
Wall Street
Price Targets
BM8 Price Targets Summary
Biomarin Pharmaceutical Inc
According to Wall Street analysts, the average 1-year price target for
BM8
is 79.54 EUR
with a low forecast of 51.1 EUR and a high forecast of 108.02 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is BM8's stock price target?
Price Target
79.54
EUR
According to Wall Street analysts, the average 1-year price target for
BM8
is 79.54 EUR
with a low forecast of 51.1 EUR and a high forecast of 108.02 EUR.
What is Biomarin Pharmaceutical Inc's Revenue forecast?
Projected CAGR
8%
For the last 13 years the
compound annual growth rate for
Biomarin Pharmaceutical Inc's revenue is
15%.
The projected
CAGR
for the next 4 years is
8%.
What is Biomarin Pharmaceutical Inc's Operating Income forecast?
Projected CAGR
22%
The
compound annual growth rate
of Biomarin Pharmaceutical Inc's operating income for the next 4 years is
22%.
What is Biomarin Pharmaceutical Inc's Net Income forecast?
Projected CAGR
33%
The
compound annual growth rate
of Biomarin Pharmaceutical Inc's net income for the next 4 years is
33%.
